October
Read articles from the October 2019 issue of PediatricsOnline.
Read articles from the October 2019 issue of PediatricsOnline.
20 years ago, treatment options were limited for children with functional GI and motility disorders. Now a growing list of therapies are transforming pediatric GI care.
Patients with cystic fibrosis show transcriptomic changes after starting treatment with lumacaftor/ivacaftor.
Study suggests doses should be tailored to each patient.
Here’s the latest on diagnosis, patient management and clinical need for hypophosphatasia’s only medical treatment: asfotase alfa enzyme replacement therapy (AA ERT).